Skip to content

The Effect of Vitamin D on Bone Accretion and Turn-Over in Young Girls

Adolescent Girls-Impact of Vitamin D on Bone Accretion Work Package 1 (Danish Part) of OPTIFORD (Towards A Strategy for Optimal Vitamin D Fortification)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00267540
Enrollment
225
Registered
2005-12-21
Start date
2001-01-31
Completion date
2003-12-31
Last updated
2008-01-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vitamin D Deficiency

Keywords

Vitamin D, adolescent girls, bone accretion, bone turn over, vitamin D status, Vitamin D insufficiency in young girls

Brief summary

Objectives To evaluate the effect of increased vitamin D intake on vitamin D status, bone mass and bone turnover in young girls aged 12-13. More specifically the effects on the following parameters will be assessed: * Vitamin D metabolites. * Parathyroid hormone. * Bone turnover. * Bone mineral accretion. * Serum calcium and phosphate. * Renal handling of calcium and phosphate.

Detailed description

This work package will consist of a randomised double blind one-year vitamin D supplementation study. Primary effect parameter is change in bone mineral content and therefore study duration will be one year. A total of 225 subjects, 75 in each of the three groups: one control and two intervention groups, will be included Two dosages of supplementation will be used: 5 µg per day and 10 µg per day.

Interventions

BEHAVIORALcholecalciferol (D3) (vitamin)

Sponsors

Seventh Framework Programme
CollaboratorOTHER
University of Copenhagen
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE

Eligibility

Sex/Gender
FEMALE
Age
10 Years to 11 Years
Healthy volunteers
Yes

Inclusion criteria

* Girls born in Denmark with Danish citizenship aged 10.0-11.0 years living in the municipals of Copenhagen and Frederiksberg

Exclusion criteria

* Any chronical disease with influence on bone mass or turnover * Intake of drugs with influence on bone mass or turnover * Intake of calcium or vitamin D other than the intervention

Design outcomes

Primary

MeasureTime frame
Vitamin D level (status) measured as s-25 hydroxy vitamin D at baseline, after half a year and one year.
Bone accretion measured by DXA. Measurement at baseline and after one year.
Bone turnover measured at baseline, half a year and one year

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 29, 2026